Back
Grupo Aeroportuario del Centro Norte SAB de CV 10K Form
Buy
73
OMAB
Grupo Aeroportuario del Centro Norte SAB de CV
Last Price:
72.91
Seasonality Move:
5.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OMAB News And Ratings
See the #1 stock for the next 7 days that we like better than OMAB
OMAB Financial Statistics
Sales & Book Value
Annual Sales: | $593.23M |
---|---|
Cash Flow: | $32.61M |
Price / Cash Flow: | 18.04 |
Annual Sales: | $9.17 |
Price / Book: | 7.96 |
Profitability
EPS (TTM): | 4.09590 |
---|---|
Net Income (TTM): | $197.75M |
Gross Margin: | $364.76M |
Return on Equity: | 47.25% |
Return on Assets: | 17.64% |
Grupo Aeroportuario del Centro Norte SAB de CV Earnings Forecast
Key Grupo Aeroportuario del Centro Norte SAB de CV Financial Ratios
- The Gross Profit Margin over the past 18 years for OMAB is 61.49%.
- The Selling, General & Administrative Expenses for OMAB have been equal to 5.59% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 23.95% of Operating Income.
- The Net Earning history of OMAB is 32.69% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 12 years.
Grupo Aeroportuario del Centro Norte SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Airports & Air Services |
Sector: | Industrials |
Current Symbol: | OMAB |
CUSIP: | 400501 |
Website: | oma.aero |
Debt
Debt-to-Equity Ratio: | 1.33 |
---|---|
Current Ratio: | 2 |
Quick Ratio: | 1.7 |
Price-to-Earnings
Trailing P/E Ratio: | 18.17 |
---|---|
Forward P/E Ratio: | 13.18 |
OMAB Technical Analysis vs Fundamental Analysis
Buy
73
Grupo Aeroportuario del Centro Norte SAB de CV (OMAB)
is a Buy
Is Grupo Aeroportuario del Centro Norte SAB de CV a Buy or a Sell?
-
Grupo Aeroportuario del Centro Norte SAB de CV stock is rated a Buy
The current Grupo Aeroportuario del Centro Norte SAB de CV [OMAB] share price is $72.97. The Score for OMAB is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.